Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

Neurochemical markers of amyotrophic lateral sclerosis (ALS) that reflect underlying disease mechanisms might help in diagnosis, staging and prediction of outcome. We aimed at determining the origin and differential diagnostic and prognostic potential of the putative marker of microglial activation...

Full description

Bibliographic Details
Main Authors: Steinacker, P, Verde, F, Fang, L, Feneberg, E, Oeckl, P, Roeber, S, Anderl-Straub, S, Danek, A, Diehl-Schmid, J, Fassbender, K, Fliessbach, K, Foerstl, H, Giese, A, Jahn, H, Kassubek, J, Kornhuber, J, Landwehrmeyer, G, Lauer, M, Pinkhardt, E, Prudlo, J, Rosenbohm, A, Schneider, A, Schroeter, M, Tumani, H, Von Arnim, C, Weishaupt, J, Weydt, P, Ludolph, A, Yilmazer Hanke, D, Otto, M, Ftldc Study Group
Format: Journal article
Language:English
Published: BMJ Publishing Group 2017
_version_ 1797062048235913216
author Steinacker, P
Verde, F
Fang, L
Feneberg, E
Oeckl, P
Roeber, S
Anderl-Straub, S
Danek, A
Diehl-Schmid, J
Fassbender, K
Fliessbach, K
Foerstl, H
Giese, A
Jahn, H
Kassubek, J
Kornhuber, J
Landwehrmeyer, G
Lauer, M
Pinkhardt, E
Prudlo, J
Rosenbohm, A
Schneider, A
Schroeter, M
Tumani, H
Von Arnim, C
Weishaupt, J
Weydt, P
Ludolph, A
Yilmazer Hanke, D
Otto, M
Ftldc Study Group
author_facet Steinacker, P
Verde, F
Fang, L
Feneberg, E
Oeckl, P
Roeber, S
Anderl-Straub, S
Danek, A
Diehl-Schmid, J
Fassbender, K
Fliessbach, K
Foerstl, H
Giese, A
Jahn, H
Kassubek, J
Kornhuber, J
Landwehrmeyer, G
Lauer, M
Pinkhardt, E
Prudlo, J
Rosenbohm, A
Schneider, A
Schroeter, M
Tumani, H
Von Arnim, C
Weishaupt, J
Weydt, P
Ludolph, A
Yilmazer Hanke, D
Otto, M
Ftldc Study Group
author_sort Steinacker, P
collection OXFORD
description Neurochemical markers of amyotrophic lateral sclerosis (ALS) that reflect underlying disease mechanisms might help in diagnosis, staging and prediction of outcome. We aimed at determining the origin and differential diagnostic and prognostic potential of the putative marker of microglial activation chitotriosidase (CHIT1).Altogether 316 patients were included, comprising patients with sporadic ALS, ALS mimics (disease controls (DCo)), frontotemporal lobar degeneration (FTLD), Creutzfeldt-Jakob disease (CJD), Alzheimer's disease (AD), Parkinson's disease (PD) and healthy controls (Con). CHIT1 and neurofilament levels were determined in cerebrospinal fluid (CSF) and blood and analysed with regard to diagnostic sensitivity and specificity and prognostic performance. Additionally, postmortem tissue was analysed for CHIT1 expression.In ALS, CHIT1 CSF levels were higher compared with Con (p<0.0001), DCo (p<0.05) and neurodegenerative diseases (AD p<0.05, PD p<0.01, FTLD p<0.0001) except CJD. CHIT1 concentrations were correlated with ALS disease progression and severity but not with the survival time, as did neurofilaments. Serum CHIT1 levels were not different in ALS compared with any other study group. In the spinal cord of patients with ALS, but not Con, AD or CJD cases, CHIT1 was expressed in the corticospinal tract and CHIT1 staining colocalised with markers of microglia (IBA1) and macrophages (CD68).CHIT1 concentrations in the CSF of patients with ALS may reflect the extent of microglia/macrophage activation in the white matter of the spinal cord. CHIT1 could be a potentially useful marker for differential diagnosis and prediction of disease progression in ALS and, therefore, seems suitable as a supplemental marker for patient stratification in therapeutic trials.
first_indexed 2024-03-06T20:39:58Z
format Journal article
id oxford-uuid:33f39dce-e636-407b-8046-72b100fb0ac0
institution University of Oxford
language English
last_indexed 2024-03-06T20:39:58Z
publishDate 2017
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:33f39dce-e636-407b-8046-72b100fb0ac02022-03-26T13:23:07ZChitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progressionJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:33f39dce-e636-407b-8046-72b100fb0ac0EnglishSymplectic Elements at OxfordBMJ Publishing Group2017Steinacker, PVerde, FFang, LFeneberg, EOeckl, PRoeber, SAnderl-Straub, SDanek, ADiehl-Schmid, JFassbender, KFliessbach, KFoerstl, HGiese, AJahn, HKassubek, JKornhuber, JLandwehrmeyer, GLauer, MPinkhardt, EPrudlo, JRosenbohm, ASchneider, ASchroeter, MTumani, HVon Arnim, CWeishaupt, JWeydt, PLudolph, AYilmazer Hanke, DOtto, MFtldc Study GroupNeurochemical markers of amyotrophic lateral sclerosis (ALS) that reflect underlying disease mechanisms might help in diagnosis, staging and prediction of outcome. We aimed at determining the origin and differential diagnostic and prognostic potential of the putative marker of microglial activation chitotriosidase (CHIT1).Altogether 316 patients were included, comprising patients with sporadic ALS, ALS mimics (disease controls (DCo)), frontotemporal lobar degeneration (FTLD), Creutzfeldt-Jakob disease (CJD), Alzheimer's disease (AD), Parkinson's disease (PD) and healthy controls (Con). CHIT1 and neurofilament levels were determined in cerebrospinal fluid (CSF) and blood and analysed with regard to diagnostic sensitivity and specificity and prognostic performance. Additionally, postmortem tissue was analysed for CHIT1 expression.In ALS, CHIT1 CSF levels were higher compared with Con (p<0.0001), DCo (p<0.05) and neurodegenerative diseases (AD p<0.05, PD p<0.01, FTLD p<0.0001) except CJD. CHIT1 concentrations were correlated with ALS disease progression and severity but not with the survival time, as did neurofilaments. Serum CHIT1 levels were not different in ALS compared with any other study group. In the spinal cord of patients with ALS, but not Con, AD or CJD cases, CHIT1 was expressed in the corticospinal tract and CHIT1 staining colocalised with markers of microglia (IBA1) and macrophages (CD68).CHIT1 concentrations in the CSF of patients with ALS may reflect the extent of microglia/macrophage activation in the white matter of the spinal cord. CHIT1 could be a potentially useful marker for differential diagnosis and prediction of disease progression in ALS and, therefore, seems suitable as a supplemental marker for patient stratification in therapeutic trials.
spellingShingle Steinacker, P
Verde, F
Fang, L
Feneberg, E
Oeckl, P
Roeber, S
Anderl-Straub, S
Danek, A
Diehl-Schmid, J
Fassbender, K
Fliessbach, K
Foerstl, H
Giese, A
Jahn, H
Kassubek, J
Kornhuber, J
Landwehrmeyer, G
Lauer, M
Pinkhardt, E
Prudlo, J
Rosenbohm, A
Schneider, A
Schroeter, M
Tumani, H
Von Arnim, C
Weishaupt, J
Weydt, P
Ludolph, A
Yilmazer Hanke, D
Otto, M
Ftldc Study Group
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title_full Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title_fullStr Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title_full_unstemmed Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title_short Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
title_sort chitotriosidase chit1 is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
work_keys_str_mv AT steinackerp chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT verdef chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT fangl chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT feneberge chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT oecklp chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT roebers chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT anderlstraubs chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT daneka chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT diehlschmidj chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT fassbenderk chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT fliessbachk chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT foerstlh chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT giesea chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT jahnh chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT kassubekj chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT kornhuberj chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT landwehrmeyerg chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT lauerm chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT pinkhardte chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT prudloj chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT rosenbohma chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT schneidera chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT schroeterm chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT tumanih chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT vonarnimc chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT weishauptj chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT weydtp chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT ludolpha chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT yilmazerhanked chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT ottom chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression
AT ftldcstudygroup chitotriosidasechit1isincreasedinmicrogliaandmacrophagesinspinalcordofamyotrophiclateralsclerosisandcerebrospinalfluidlevelscorrelatewithdiseaseseverityandprogression